on 26 Mar 2024
Last Applicant/ Owned by
1 Princeton Mews,
GB
Serial Number
79347617 filed on 26th May 2022
Registration Number
7333791 registered on 26th Mar 2024
Correspondent Address
Catherine J. Holland
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
Pharmaceutical research and development in the field of biotechnology, medical devices in the field of drug delivery systems; scientific research for clinical, medical and pharmaceutical purposes in the field of biotechnology, medical devices for drug delivery systems and life sciences; scientific research and development in the field of biotechnology medical devices, life sciences and healthcare Read More
Licensing of intellectual property rights; licensing of intellectual property in the field of pharmaceutical, biotechnology, life sciences; none of the aforesaid being in relation to the examination, processing, transportation or testing services relating to veterinary or medical samples; none of the aforesaid services being in relation to diagnostic applications by means of medical samples or in the field of laboratory automation for diagnostic purposes by means of medical samples, specimen handling or sample preparation or being in the field of software and IT services for enabling and/or supporting medical, patient and veterinary sample data testing, processing and/or analysis
Pharmaceutical research and development in the field of biotechnology, medical devices in the field of drug delivery systems; scientific research for clinical, medical and pharmaceutical purposes in the field of biotechnology, medical devices for drug delivery systems and life sciences; scientific research and development in the field of biotechnology medical devices, life sciences and healthcare technology; pharmaceutical products development and medical device product development in the field of biotechnology, medical devices for drug delivery systems and life sciences; none of the aforesaid being in relation to the examination, processing, transportation or testing services relating to veterinary; none of the aforesaid services being in relation to diagnostic applications by means of medical samples or in the field of laboratory automation for diagnostic purposes by means of medical samples, specimen handling or sample preparation or being in the field of software and IT services for enabling and/or supporting medical, patient and veterinary sample data testing, processing and/or analysis
Financing and equity investment services in the fields of pharmaceuticals, biotechnology life sciences; capital financing services in the fields of pharmaceuticals, biotechnology, life sciences; making direct and indirect investments, namely providing venture capital, private equity and investment funding for the development and commercialization of products and management of product portfolios in the fields of pharmaceuticals, biotechnology, life sciences; investment services, namely, asset and investment acquisition, and development services; none of the aforesaid services being in relation to the examination, processing, transportation or testing services relating to veterinary or medical samples; none of the aforesaid services being in relation to diagnostic applications by means of medical samples or in the field of laboratory automation for diagnostic purposes by means of medical samples, specimen handling or sample preparation or being in the field of software and IT services for enabling and/or supporting medical, patient and veterinary sample data testing, processing and/or analysis
Surgical instruments and apparatus, and medical devices, namely, inhalation devices in the field of drug delivery systems, excluding medical and veterinary sample containers, processing and analysis machines and test kits and personal protective equipment (PPE); inhalers for medical and pharmaceutical purposes; none of the aforesaid being goods for use in the examination, processing, transportation or testing of veterinary or medical samples or for use in diagnostics or in laboratory automation for diagnostic purposes, sample handling or sample preparation enabling and/or supporting medical, patient and veterinary data testing, processing and/or analysis
Pharmaceuticals for use in oncology, cardio-respiratory, haematology and immunity, paediatric and regenerative medicine; Pharmaceutical preparations and substances for oncology, cardio-respiratory, haematology and immunity, paediatric and regenerative medicine and for the prevention and treatment of inflammation and infectious diseases; chemical preparations for pharmaceutical purposes, namely, for use in oncology, cardio-respiratory, haematology and immunity, paediatric and regenerative medicine and for the treatment of inflammation and infectious diseases; chemical reagents for medical use; biotechnological preparations for medical use for use in oncology, cardio-respiratory, haematology and immunity, paediatric and regenerative medicine and for the treatment of inflammation and infectious diseases; biological adjuvants for medical purposes; biochemical preparations for medical use for use in oncology, cardio-respiratory, haematology and immunity, paediatric and regenerative medicine and for the treatment of inflammation and infectious diseases; preparations for deodorizing air; medicated deodorants for health and medical purposes; oils for medical purposes; air purifying preparations, pharmaceutical preparations for inhalers; none of the aforesaid goods being disinfectants or sanitary preparations, and not being adapted for use as disinfectant or sanitisers; none of the aforesaid being goods for use in diagnostics or for use in the examination, processing, transportation or testing of veterinary or medical samples
No 79347617
No Service Mark
No TAW026.001IU
No
No
No
No
Yes
Yes
No
No
| Status Date | Action Taken |
|---|---|
| 26th Mar 2024 | REGISTERED-PRINCIPAL REGISTER |
| 26th Mar 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 13th Feb 2024 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| 24th Jan 2024 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| 24th Jan 2024 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| 09th Jan 2024 | PUBLISHED FOR OPPOSITION |
| 09th Jan 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 08th Jan 2024 | NOTIFICATION PROCESSED BY IB |
| 20th Dec 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 20th Dec 2023 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
